Medication info
Candemor Plus Tablets 16/12.5 mg

Candemor Plus Tablets 16/12.5 mg

Prescription medicationTabletOral
Ingredient · strength
Candesartan Cilexetil›16mgHydrochlorothiazide›12.5mg
Manufacturer / importer
Jongkun Dang Co., Ltd.
Appearance
Biconvex light orange oval tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 200901207 · Notified 2009.02.12 · Insurance code 643305240

Summary

Main use
Treatment of essential hypertension not controlled by treatment with individual components
Who takes it
Adults
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with or without food. 1) Adults: Before switching to this medicine, the dose of candesartan cilexetil should first be adjusted. When clinically appropriate, a direct switch from monotherapy to this medicine may be considered. The antihypertensive effect is usually achieved within 4 weeks of starting treatment. 2) Elderly patients: No dose adjustment of this medicine is necessary in elderly patients. 3) Patients with intravascular volume depletion: Dose adjustment of candesartan cilexetil is recommended in patients at risk of hypotension, such as those who may have reduced effective blood volume (the initial dose of candesartan cilexetil in these patients is 4 milligrams). 4) Patients with renal impairment: In patients with mild to moderate renal impairment and creatinine clearance of 30-80ml/min/1.73㎡ BSA, consider adjusting the dose of candesartan cilexetil before switching to this medicine (the initial dose of candesartan cilexetil in these patients is 4 milligrams). Do not administer to patients with severe renal impairment (creatinine clearance less than 30ml/mim/1.73㎡ BSA). 5) Patients with hepatic impairment: Dose adjustment of candesartan cilexetil is recommended before administering this medicine to patients with mild to moderate hepatic impairment (the initial dose of candesartan cilexetil in these patients is 2 milligrams). Do not administer to patients with severe hepatic impairment or cholestasis.

Ingredients

Manufacturer
Jongkun Dang Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled by treatment with individual components

  • Essential hypertension
View approved original text

Essential hypertension is a condition characterized by persistently high blood pressure due to various factors. This medication is used when individual component treatment alone does not demonstrate sufficient effect, effectively controlling blood pressure. It helps stabilize the patient's blood pressure and reduce the risk of cardiovascular complications. Through safe and steady use, it aids in maintaining healthy blood pressure. This drug is used for the treatment of essential hypertension.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with or without food. 1) Adults: Before switching to this medicine, the dose of candesartan cilexetil should first be adjusted. When clinically appropriate, a direct switch from monotherapy to this medicine may be considered. The antihypertensive effect is usually achieved within 4 weeks of starting treatment. 2) Elderly patients: No dose adjustment of this medicine is necessary in elderly patients. 3) Patients with intravascular volume depletion: Dose adjustment of candesartan cilexetil is recommended in patients at risk of hypotension, such as those who may have reduced effective blood volume (the initial dose of candesartan cilexetil in these patients is 4 milligrams). 4) Patients with renal impairment: In patients with mild to moderate renal impairment and creatinine clearance of 30-80ml/min/1.73㎡ BSA, consider adjusting the dose of candesartan cilexetil before switching to this medicine (the initial dose of candesartan cilexetil in these patients is 4 milligrams). Do not administer to patients with severe renal impairment (creatinine clearance less than 30ml/mim/1.73㎡ BSA). 5) Patients with hepatic impairment: Dose adjustment of candesartan cilexetil is recommended before administering this medicine to patients with mild to moderate hepatic impairment (the initial dose of candesartan cilexetil in these patients is 2 milligrams). Do not administer to patients with severe hepatic impairment or cholestasis.

Precautions

This medication may increase the risk of severe harm or death to the fetus and newborn during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately upon confirmation of pregnancy. Individuals allergic to this drug's components or sulfonamide-class drugs, pregnant women or those planning to become pregnant, and patients with severe kidney or liver dysfunction should not take this medication. Patients with decreased blood volume or electrolyte imbalances, liver disease patients, individuals with heart valve problems, patients with hyperkalemia, the elderly, and patients with certain diseases should use this drug cautiously. This medication lowers blood pressure, so symptoms of sudden hypotension or dizziness may occur, and electrolyte imbalances may arise due to its diuretic effect, thus regular blood tests and following the physician's guidance are necessary. Due to the hydrochlorothiazide component, the skin may become sensitive to sunlight, necessitating attention to UV protection and skin care, as there is an increased risk of non-melanoma skin cancer, making it essential to periodically check skin condition. During the course of this medication, interactions may occur with other blood pressure medications, diuretics, potassium supplements, specific antibiotics, non-steroidal anti-inflammatory drugs (NSAIDs), so it is critical to inform the doctor or pharmacist of any currently taken medications. Breastfeeding women should consult a doctor or discontinue breastfeeding as this medication may pass into breast milk, and its safety and efficacy in children or adolescents under 18 years are not established. In case of overdose, symptoms such as hypotension, dizziness, and electrolyte imbalance may occur, requiring immediate visit to a medical institution, and it should be stored out of reach of children in its original container for safety. Caution is advised when driving or operating machinery as dizziness or fatigue may occur.

Side effects

  • Headache
  • back pain
  • dizziness
  • respiratory tract infection
  • symptoms similar to influenza
  • sinusitis
  • bronchitis
  • urinary tract infection
  • nausea
  • contusion
Show 74 more
  • tachycardia
  • fatigue
  • abdominal pain
  • pharyngitis
  • atrioventricular block
  • vomiting
  • dyslipidemia
  • rhinitis
  • cough
  • elevated blood sugar
  • elevated serum uric acid
  • increased ALT
  • decreased hemoglobin
  • increased serum AST
  • increased creatinine
  • increased urea
  • elevated potassium
  • decreased sodium
  • leukopenia
  • neutropenia
  • agranulocytosis
  • vertigo
  • intestinal vascular edema
  • diarrhea
  • renal failure
  • angioedema
  • rash
  • urticaria
  • pruritus
  • arthralgia
  • myalgia
  • hyperkalemia
  • hyponatremia
  • increased liver enzyme levels
  • abnormal liver function
  • hepatitis
  • increased cholesterol
  • increased triglycerides
  • venous thrombosis
  • sensory disturbances
  • transient visual disturbance
  • choroidal effusion
  • acute myopia
  • acute angle-closure glaucoma
  • dyspnea
  • acute respiratory distress syndrome
  • loss of appetite
  • appetite loss
  • gastrointestinal irritation
  • constipation
  • pancreatitis
  • interstitial nephritis
  • rash
  • photosensitivity reaction
  • toxic epidermal necrolysis
  • skin erythematous lupus-like reaction
  • activation of erythematous lupus
  • muscle cramps
  • hyperglycemia
  • hyperuricemia
  • electrolyte imbalance
  • orthostatic hypotension
  • necrotizing vasculitis
  • weakness
  • fever
  • anaphylactic reaction
  • jaundice
  • sleep disturbances
  • depression
  • anxiety
  • edema
  • myalgia
  • hypercalcemia
  • otalgia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air or moisture from entering, and it is best kept in a cool place at temperatures below 30 degrees Celsius. This will help maintain the medication's effectiveness and prevent deterioration.

Appearance and packaging

Appearance

Biconvex light orange oval tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.